Joseph K. Belanoff
Chief Executive Officer at Corcept Therapeutics Incorporated
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Corcept Therapeutics Incorporated, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Corcept Therapeutics Incorporated May 21, 202699.6%
-
Corcept Therapeutics Incorporated June 10, 202599.8%
-
Corcept Therapeutics Incorporated May 17, 202499.6%
-
Corcept Therapeutics Incorporated May 19, 202399.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1, 2026 | Corcept Therapeutics Incorporated | Open-market sale | −12,837 | $69.74 | $895,252 |
| May 29, 2026 | Corcept Therapeutics Incorporated | Gift | −300,000 | — | — |
| May 29, 2026 | Corcept Therapeutics Incorporated | Gift | +150,000 | — | — |
| May 29, 2026 | Corcept Therapeutics Incorporated | Gift | +150,000 | — | — |
| May 1, 2026 | Corcept Therapeutics Incorporated | Open-market sale | −40,000 | $50.10 | $2,004,000 |
| Mar 25, 2026 | Corcept Therapeutics Incorporated | Open-market sale | −26,198 | $50.07 | $1,311,734 |
| Dec 24, 2025 | Corcept Therapeutics Incorporated | Option exercise | +550,000 | $3.88 | $2,134,000 |
| Dec 24, 2025 | Corcept Therapeutics Incorporated | Shares withheld for tax | −306,846 | $83.59 | $25,649,257 |
| Dec 24, 2025 | Corcept Therapeutics Incorporated | Gift | −243,154 | — | — |
| Dec 24, 2025 | Corcept Therapeutics Incorporated | Other | +243,154 | — | — |
| Dec 1, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −40,000 | $79.77 | $3,190,800 |
| Nov 5, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −14,355 | $74.20 | $1,065,141 |
| Nov 5, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −10,837 | $75.14 | $814,292 |
| Nov 5, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −3,590 | $75.98 | $272,768 |
| Nov 3, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −11,218 | $74.08 | $831,029 |
Questions about Joseph K. Belanoff
What boards is Joseph K. Belanoff on?
Joseph K. Belanoff sits on the board of Corcept Therapeutics Incorporated.
What company is Joseph K. Belanoff the CEO of?
Joseph K. Belanoff is Chief Executive Officer of Corcept Therapeutics Incorporated.
How long has Joseph K. Belanoff served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.